• Patent

Kappa opioid receptor ligands

Structurally novel kappa opioid receptor antagonists areprovided and the use of these antagonists in treatment of diseasestates that are ameliorated by binding of the kappa opioid receptorsuch as heroin or cocaine addictions.


Carroll, F., Thomas, J., & Mascarella, S. (2003). IPC No. U.S. Kappa opioid receptor ligands. (Patent No. 6559159).